<http://www.wikidata.org/entity/statement/Q63813296-17F9E2C3-66CC-4CE4-AE7D-F6E073BDCAD7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#Statement> .
<http://www.wikidata.org/entity/statement/Q63813296-17F9E2C3-66CC-4CE4-AE7D-F6E073BDCAD7>	<http://wikiba.se/ontology#rank>	<http://wikiba.se/ontology#NormalRank> .
<http://www.wikidata.org/entity/statement/Q63813296-17F9E2C3-66CC-4CE4-AE7D-F6E073BDCAD7>	<http://www.wikidata.org/prop/statement/P1476>	"Phase 3 Randomized Study Comparing X-396 (Ensartinib) to Crizotinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients"@en .
<http://www.wikidata.org/entity/statement/Q63813296-17F9E2C3-66CC-4CE4-AE7D-F6E073BDCAD7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#BestRank> .